News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Averion Inc. Chief Medical Officer - Dr. Gene Resnick - to Lead Session at New York Biotechnology Association 17th Annual Meeting



5/16/2008 10:44:12 AM

SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Averion International Corp. (OTCBB: AVRO), a clinical research organization (CRO) specializing in oncology, cardiovascular diseases, and medical devices, today announced that its Chief Medical Officer, Dr. Gene Resnick, will be moderating a session on the “Use of Biomarkers in Drug Development” at the New York Biotechnology Association (NYBA) 17th Annual Meeting. The meeting will take place on May 19-20, 2008, at the Marriott Marquis Hotel in New York City.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES